Product Information
BUPRENORPHINE 2 MG TABLET SL is a generic product labeled by Advagen Pharma Ltd., priced at $0.2629 per EA under NDC 72888018230. Its NADAC has been published 95 times since Sep 4, 2024.
Strength
2 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888018230
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090279On Market Since
6/10/2015
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 2 MG TABLET SL has been published 95 times since Sep 4, 2024, and over the history we have for it it has declined 58.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2629 per EA |
|---|---|
| All-time high | $0.6289 (Sep 11, 2024) |
| All-time low | $0.2629 (Jun 17, 2026) |
| 52-week high | $0.3346 |
| 52-week low | $0.2629 |
| Median price | $0.3179 |
| Average price | $0.3415 |
| Largest weekly change | -32.7% (Nov 20, 2024) |
| Weeks tracked | 95 |
| Tracking since | Sep 4, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 2 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 2 MG TABLET SL, manufactured by Advagen Pharma Ltd., is $0.2629 per EA (NDC 72888018230), effective Jun 24, 2026.
How has the price of BUPRENORPHINE 2 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 2 MG TABLET SL has declined 58.2%. It has been tracked across 95 weekly CMS publications since Sep 4, 2024.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 2 MG TABLET SL?
Since Sep 4, 2024, the NADAC for BUPRENORPHINE 2 MG TABLET SL has ranged from a low of $0.2629 (Jun 17, 2026) to a high of $0.6289 (Sep 11, 2024), with a median of $0.3179 per EA.
Are there cheaper alternatives to BUPRENORPHINE 2 MG TABLET SL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BUPRENORPHINE 2 MG TABLET SL, but none are currently priced below it.
Who manufactures BUPRENORPHINE 2 MG TABLET SL?
BUPRENORPHINE 2 MG TABLET SL (NDC 72888018230) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification